Axel Grothey

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson, Alan P. Venook, Lynette Cederquist et al. · Journal of the National Comprehensive Cancer Network · 2017 · 1.4K citations · Full text

Medicine, Molecular Medicine, Oncology +17

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary et al. · Journal of the National Comprehensive Cancer Network · 2018 · 994 citations · Full text

Medicine, Oncology, Surgery +17

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

Josep Tabernero, Heinz‐Josef Lenz, Salvatore Siena et al. · The Lancet Oncology · 2015 · 326 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741

Howard L. McLeod, Daniel J. Sargent, Sharon Marsh et al. · Journal of Clinical Oncology · 2010 · 216 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Phase III Trial Results of Panitumumab, a Fully Human Anti—Epidermal Growth Factor Receptor Monoclonal Antibody, in Metastatic Colorectal Cancer

Tara Beers Gibson, Aarati Ranganathan, Axel Grothey · Clinical Colorectal Cancer · 2006 · 163 citations

Medicine, Oncology, Pharmacology +12